Skip to main content

Table 2 The portion of irregular and multilayer liposomes perpared by microfluidic chip technology

From: Observation of antitumor mechanism of GE11-modified paclitaxel and curcumin liposomes based on cellular morphology changes

 

Total number

Irregular

Multilayer

CUR@L

200

1 (0.05%)

2 (0.1%)

CUR-PTX@PEG-L

300

0

5 (1.6%)

CUR-PTX @ GE 11-L

300

6 (2%)

0